AI algorithm DermSpot

for researchdermatology

World Class Algorithms Our autonomous AI research expands the reach of dermatological care beyond the exam room, from skin cancer to inflammatory disease. We are currently recruiting pilot locations and research groups interested in skin diagnostics and management. 3Derm Announces Two FDA Breakthrough Device Designations for Autonomous Skin Cancer AI DermSpot* is an algorithm that uses artificial intelligence (AI) and highly standardized skin images to autonomously detect melanoma, squamous cell carcinoma, and basal cell carcinoma. DermSpot is being developed in collaboration with primary care physicians and dermatologists across the country. Our Focus We’re committed to using technology to increase access for all patients by focusing on high-impact disease areas and solutions Diagnostic tools expedite and expand access to specialty care. Chronic disease management supports remote patient monitoring. Life sciences applications enable trial and therapy monitoring. Melanoma Melanoma is the most lethal form of skin cancer. If not caught early, there is high risk of it spreading from the skin to other tissues and parts of the body. Basal Cell Carcinoma Basal cell carcinoma is the most common form of skin cancer. BCC are slow growing and are highly curable when caught and treated early. Squamous Cell Carcinoma Squamous cell carcinoma is a slow spreading cancer. When caught and treated early, SCC is highly curable. Psoriasis Psoriasis is a chronic inflammatory skin condition. It can be managed through a variety of treatments, from topical steroids to biologics.